DRD2 and schizophrenia: The importance of dopamine neurotransmission for the pathogenesis of both bipolar disorder and schizophrenia has been suggested by both the clinical efficacy of dopamine D2 receptor antagonists in human patients and their central roles in modulating relevant behaviors in animal models.